sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type XI, alpha |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, gamma |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, delta |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type X, alpha |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage gated, type VIII, alpha |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VII, alpha |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, beta |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, alpha |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, alpha |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, beta |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, alpha 2 |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, beta |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, beta |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel associated protein 1 |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel associated protein 2 |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VII, alpha |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
amiloride-sensitive cation channel 5, intestinal |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VIII, alpha polypeptide |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type XI, alpha |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, beta |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 10, alpha polypeptide |
PROCARBAZINE |
Sodium Channel, Site 2 |
-17% |
NoneNone |
NoneNone |
View
|
nuclear receptor subfamily 3, group C, member 1 |
CHLORAMBUCIL |
Glucocorticoid |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
CANTHARIDIN |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
CANTHARIDIN |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
CANTHARIDIN |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
CANTHARIDIN |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
CANTHARIDIN |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
CANTHARIDIN |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 |
CANTHARIDIN |
Thromboxane Synthetase |
-17% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
CANTHARIDIN |
Thromboxane Synthetase |
-17% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 5 (DBSS) |
CHLORDIAZEPOXIDE |
Tumor Necrosis Factor (TNF), Non-Selective |
-17% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 1b |
CHLORDIAZEPOXIDE |
Tumor Necrosis Factor (TNF), Non-Selective |
-17% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 1a |
CHLORDIAZEPOXIDE |
Tumor Necrosis Factor (TNF), Non-Selective |
-17% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 4 |
CHLORDIAZEPOXIDE |
Tumor Necrosis Factor (TNF), Non-Selective |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
IPRONIAZID |
Serotonin 5-HT2A |
-17% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
BENZO[A]PYRENE |
Leukotriene B4 |
-17% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
BENZO[A]PYRENE |
Leukotriene B4 |
-17% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
BENZO[A]PYRENE |
Leukotriene B4 |
-17% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
BENZO[A]PYRENE |
Leukotriene B4 |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Dihydropyridine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Dihydropyridine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Dihydropyridine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Dihydropyridine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Dihydropyridine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Dihydropyridine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Dihydropyridine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Dihydropyridine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Dihydropyridine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Dihydropyridine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Dihydropyridine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Dihydropyridine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
PRAZIQUANTEL |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
PRAZIQUANTEL |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
PRAZIQUANTEL |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
PRAZIQUANTEL |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
PRAZIQUANTEL |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
PRAZIQUANTEL |
Glutamate, NMDA, Phencyclidine |
-17% |
NoneNone |
NoneNone |
View
|
androgen receptor |
PRAZIQUANTEL |
Testosterone |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
6-MERCAPTOPURINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
6-MERCAPTOPURINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
6-MERCAPTOPURINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
6-MERCAPTOPURINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
6-MERCAPTOPURINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
6-MERCAPTOPURINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
6-MERCAPTOPURINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
6-MERCAPTOPURINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
6-MERCAPTOPURINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
6-MERCAPTOPURINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
6-MERCAPTOPURINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
6-MERCAPTOPURINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
6-MERCAPTOPURINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
6-MERCAPTOPURINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
6-MERCAPTOPURINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
6-MERCAPTOPURINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
6-MERCAPTOPURINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
6-MERCAPTOPURINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
6-MERCAPTOPURINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
6-MERCAPTOPURINE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
natriuretic peptide receptor 2 |
PRALIDOXIME CHLORIDE |
Atrial Natriuretic Factor (ANF) |
-17% |
NoneNone |
NoneNone |
View
|
guanylate cyclase A/atrial natriuretic peptide receptor (Non-specific probe) |
PRALIDOXIME CHLORIDE |
Atrial Natriuretic Factor (ANF) |
-17% |
NoneNone |
NoneNone |
View
|
natriuretic peptide receptor 3 |
PRALIDOXIME CHLORIDE |
Atrial Natriuretic Factor (ANF) |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
GREPAFLOXACIN |
Glutamate, NMDA, Agonism |
-17% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
GREPAFLOXACIN |
Glutamate, NMDA, Agonism |
-17% |
NoneNone |
NoneNone |
View
|
solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 |
GADOPENTETATE DIMEGLUMINE |
Adenosine Transporter |
-17% |
NoneNone |
NoneNone |
View
|
concentrative Na+ nucleoside cotransporter (DBSS) |
GADOPENTETATE DIMEGLUMINE |
Adenosine Transporter |
-17% |
NoneNone |
NoneNone |
View
|
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
GADOPENTETATE DIMEGLUMINE |
Adenosine Transporter |
-17% |
NoneNone |
NoneNone |
View
|
adenine nucleotide translocase (DBSS) (Non-specific probe) |
GADOPENTETATE DIMEGLUMINE |
Adenosine Transporter |
-17% |
NoneNone |
NoneNone |
View
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
GADOPENTETATE DIMEGLUMINE |
Adenosine Transporter |
-17% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 3 |
SOTALOL |
Protein Serine/Threonine Kinase, ERK1 |
-17% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 3 |
SOTALOL |
Protein Serine/Threonine Kinase, ERK1 |
-17% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
PHENTOLAMINE |
Monoamine Oxidase MAOA |
-17% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
PHENTOLAMINE |
Monoamine Oxidase MAOA |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
CANDESARTAN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
CANDESARTAN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
CANDESARTAN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
CANDESARTAN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
CANDESARTAN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
CANDESARTAN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
CANDESARTAN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
CANDESARTAN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
CANDESARTAN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
CANDESARTAN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
CANDESARTAN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
CANDESARTAN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
CANDESARTAN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
CANDESARTAN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
CANDESARTAN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CANDESARTAN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
CANDESARTAN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
CANDESARTAN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
CANDESARTAN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CANDESARTAN |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, pi |
PHENTOLAMINE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
AT hook, DNA binding motif, containing 1 (DBSS) |
PHENTOLAMINE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, theta |
PHENTOLAMINE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 2 |
PHENTOLAMINE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
PHENTOLAMINE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
PHENTOLAMINE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 2 |
PHENTOLAMINE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
PHENTOLAMINE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
PHENTOLAMINE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
PHENTOLAMINE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, delta |
PHENTOLAMINE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
PHENTOLAMINE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
PHENTOLAMINE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 1 |
PHENTOLAMINE |
GABAA, Chloride Channel, TBOB |
-17% |
NoneNone |
NoneNone |
View
|
dopamine receptor 2 |
PHENACETIN |
Dopamine D2L |
-17% |
NoneNone |
NoneNone |
View
|
lymphocyte protein tyrosine kinase (mapped) |
NOSCAPINE |
Protein Tyrosine Kinase, Lck |
-17% |
NoneNone |
NoneNone |
View
|
protein kinase C, mu |
PROBUCOL |
Phorbol Ester |
-17% |
NoneNone |
NoneNone |
View
|
protein kinase C, theta |
PROBUCOL |
Phorbol Ester |
-17% |
NoneNone |
NoneNone |
View
|
protein kinase C, iota |
PROBUCOL |
Phorbol Ester |
-17% |
NoneNone |
NoneNone |
View
|
protein kinase C, epsilon |
PROBUCOL |
Phorbol Ester |
-17% |
NoneNone |
NoneNone |
View
|
protein kinase C, zeta |
PROBUCOL |
Phorbol Ester |
-17% |
NoneNone |
NoneNone |
View
|
protein kinase C, gamma |
PROBUCOL |
Phorbol Ester |
-17% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
PROBUCOL |
Phorbol Ester |
-17% |
NoneNone |
NoneNone |
View
|
protein kinase C, delta |
PROBUCOL |
Phorbol Ester |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
VALPROIC ACID |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
VALPROIC ACID |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
VALPROIC ACID |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
VALPROIC ACID |
Calcium Channel Type L, Benzothiazepine |
-17% |
NoneNone |
NoneNone |
View
|
arachidonate 15-lipoxygenase, second type |
ATORVASTATIN |
Lipoxygenase 15-LO |
-17% |
NoneNone |
NoneNone |
View
|
arachidonate 15-lipoxygenase |
ATORVASTATIN |
Lipoxygenase 15-LO |
-17% |
NoneNone |
NoneNone |
View
|
arachidonate 15-lipoxygenase |
ATORVASTATIN |
Lipoxygenase 15-LO |
-17% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
LAMOTRIGINE |
CYP450-1A2 Inhibition |
-17% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 4 |
CLOZAPINE |
Chemokine CCR4 |
-17% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
CLEMASTINE |
Leukotriene C4 Synthetase |
-17% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
CLEMASTINE |
Leukotriene C4 Synthetase |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 5 |
OXYMETHOLONE |
Muscarinic M5 |
-17% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2a |
GALLAMINE TRIETHIODIDE |
Imidazoline I2, Central |
-17% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
GALLAMINE TRIETHIODIDE |
Imidazoline I2, Central |
-17% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
FLUDARABINE |
Cyclooxygenase COX-2 |
-17% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
FLUDARABINE |
Cyclooxygenase COX-2 |
-17% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase 5a, mitochondrial |
THIMEROSAL |
Carbonic Anhydrase |
-17% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase 3 |
THIMEROSAL |
Carbonic Anhydrase |
-17% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase 2 |
THIMEROSAL |
Carbonic Anhydrase |
-17% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase 4 |
THIMEROSAL |
Carbonic Anhydrase |
-17% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase XI |
THIMEROSAL |
Carbonic Anhydrase |
-17% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase IX |
THIMEROSAL |
Carbonic Anhydrase |
-17% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VIII |
THIMEROSAL |
Carbonic Anhydrase |
-17% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VII |
THIMEROSAL |
Carbonic Anhydrase |
-17% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VA, mitochondrial |
THIMEROSAL |
Carbonic Anhydrase |
-17% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase IV |
THIMEROSAL |
Carbonic Anhydrase |
-17% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase III, muscle specific |
THIMEROSAL |
Carbonic Anhydrase |
-17% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase I |
THIMEROSAL |
Carbonic Anhydrase |
-17% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase XIV |
THIMEROSAL |
Carbonic Anhydrase |
-17% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VB, mitochondrial |
THIMEROSAL |
Carbonic Anhydrase |
-17% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase XII |
THIMEROSAL |
Carbonic Anhydrase |
-17% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VI |
THIMEROSAL |
Carbonic Anhydrase |
-17% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase II |
THIMEROSAL |
Carbonic Anhydrase |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 4 |
DESOXIMETASONE |
Muscarinic M4 |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
THIOGUANINE |
Glutamate, AMPA |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA2 |
THIOGUANINE |
Glutamate, AMPA |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA3 (alpha 3) |
THIOGUANINE |
Glutamate, AMPA |
-17% |
NoneNone |
NoneNone |
View
|
glutamate receptor subunit 4c |
THIOGUANINE |
Glutamate, AMPA |
-17% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 1 |
BENAZEPRIL |
Muscarinic M1 |
-17% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2D6 monooxygenase |
BENZBROMARONE |
CYP450-2D6 Inhibition |
-17% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 1B |
BENZOIC ACID |
Serotonin 5-HT1B |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
CORTISONE ACETATE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
CORTISONE ACETATE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
CORTISONE ACETATE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
CORTISONE ACETATE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
CORTISONE ACETATE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
CORTISONE ACETATE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
CORTISONE ACETATE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
CORTISONE ACETATE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
CORTISONE ACETATE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
CORTISONE ACETATE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
CORTISONE ACETATE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
CORTISONE ACETATE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
CORTISONE ACETATE |
Calcium Channel Type L, Phenylalkylamine |
-17% |
NoneNone |
NoneNone |
View
|